Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Tuesday, February 19, 2013
Changing markets and potential solutions will be the highlight at the 15th Pharma Congress Production & Technology in Duesseldorf, Germany, March 19 - 20. Vetter, one of the worlds’ leading Contract and Development Manufacturing Organization, will ...
read more
Pinnaql has acquired Validation & Engineering Group, Inc. (VEG), a provider of commissioning, qualification, and validation (CQV) services to the pharmaceutical and life sciences industries.
read more
Piramal Pharma Limited's Pharma Solutions business announced a new production block has come online at the company's drug product site in Pithampur, in the state of Madhya Pradesh, India.
read more
Clearwater, Florida -- CoreRx, Inc. today announced plans for an approximately $2 million expansion of its manufacturing capabilities in Clearwater, Florida. The expansion will introduce a new facility for hormone development, clinical trial ...
read more
Philogen S.p.A has entered into a Service and Supply Agreement with IBSA (Institut Biochimique SA) to produce a recombinant therapeutic protein at Philogen GMP Facilities in Siena (Italy).
read more
Aldena Therapeutics, a private biotech company pioneering siRNA- based therapies for dermatological indications, has chosen PCI Pharma Services (PCI), a global contract development and manufacturing organization (CDMO) to formulate, package, and ...
read more
Inotiv, Inc. announced today that the Company has entered into an agreement and plan of merger with Bolder BioPATH, Inc., a contract pharmacology and pathology company.
read more
Tuesday, November 12, 2024
Adragos Pharmahas enhanced its production capabilities with the completion of a new ampoule filling line at its Livron-sur-Drôme site in France.
read more
Monday, September 10, 2018
Opiant and Consort announced a development and manufacturing agreement for Opiant’s OPNT003, a potent, long-acting opioid antagonist for the treatment of opioid overdose.
read more
Tuesday, November 08, 2011
Sentinel Capital Partners, a private equity firm that invests in promising lower middle market companies, today announced its acquisition of WellSpring Pharmaceutical Corporation, a North American manufacturer and marketer of specialty prescription ...
read more
Tuesday, December 02, 2014
Vetter has announced a major milestone in the issue of drug safety. The contract development and manufacturing organization (CDMO) now offers the option of clearly identifying packaging used for drugs. Vetter's comprehensive and flexible ...
read more
Advent International, one of the largest and most experienced global private equity investors, and Warburg Pincus, a leading global growth investor, today announced the completion of their previously announced acquisition of Baxter International’s ...
read more
Tuesday, February 07, 2017
Catalent, a global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, has announced financial results for the second quarter of fiscal year 2017, which ended December 31, 2016.
read more
Wednesday, September 26, 2018
Experic announced that Justin Lacombe, Ph.D. has joined its leadership team as Director of Pharmaceutical Development and Manufacturing Services.
read more
Gallus BioPharmaceuticals, LLC (Gallus), a premier
pure-play biologics contract manufacturing organization (CMO) has signed a manufacturing
agreement with Symphogen, A/S (Symphogen), a private biopharmaceutical company developing
recombinant ...
read more